Results 61 to 70 of about 1,656,609 (285)

Investigation of PON1 activity and MDA levels in patients with epilepsy not receiving antiepileptic treatment

open access: yesNeuropsychiatric Disease and Treatment, 2016
Nilüfer Dönmezdil, Mehmet Uğur Çevik, Hasan Hüseyin Özdemir, Muhterem Taşin Department of Neurology, Dicle University, Diyarbakır, Turkey Purpose: There are many studies dedicated to researching the ...
Dönmezdil N   +3 more
doaj  

Quality improvement in neurology

open access: yesNeurology, 2018
Epilepsy is a common condition in the United States. It is estimated that 1.2% of the population or 3.4 million people have epilepsy. This figure may be underestimated because of potential repercussions and stigma in disclosing epilepsy.1 Studies have ...
Anup D. Patel   +14 more
semanticscholar   +1 more source

Pre‐Diagnostic Features of Multiple Sclerosis in a Diverse UK Cohort: A Nested Case–Control Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Many patients with Multiple Sclerosis (MS) experience nonspecific symptoms prior to diagnosis. This period—the 'MS prodrome'—has been described in socio‐economically homogeneous cohorts to date. It remains unclear to what extent events prior to an MS diagnosis differ according to social determinants of health. Methods We conducted a
Pooja Tank   +3 more
wiley   +1 more source

Genetic Modifiers of Parkinson's Disease: A Case–Control Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the associations of LRRK2 p.G2019S, GBA1 p.N409S, polygenic risk scores (PRS), and APOE E4 on PD penetrance, risk, and symptoms. Methods We conducted a US‐based observational case–control study using data from the 23andMe Inc. and Fox Insight Genetic Substudy (FIGS) databases.
Matthew J. Kmiecik   +15 more
wiley   +1 more source

Cerebral Amyloid Angiopathy-Related Inflammation: Clinical Characteristics and Treatment Experience

open access: yesClinical Interventions in Aging
Xue Wang,1,* Jiaqi Li,1,* Qichang Fu,2,* Honglin Zheng,1,3 Suying Duan,1 Yuan Gao,1,4 Haiyang Luo,1,3 Yuming Xu1,3,4 1Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou,
Wang X   +7 more
doaj  

Plasma Glial Fibrillary Acidic Protein Correlates With Brain Metal Burden in Wilson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuroinflammation driven by extracellular copper contributes to neuronal damage in Wilson's disease (WD). This study investigated the relationship between brain metal burden and peripheral neuroinflammation markers in WD. Methods We conducted a cross‐sectional study involving 89 participants, including patients with WD (n = 63 ...
Sung‐Pin Fan   +12 more
wiley   +1 more source

Phenotypic Manifestations in Two Cases of Osmotic Demyelination Syndrome

open access: yesInternational Medical Case Reports Journal
Noon Elimam,1 Eman Elimam,2 Victoria Krylova,1 Oleg Lobanov,3 Larysa Panteleienko1,4 1Department of Neurology, Bogomolets National Medical University, Kyiv, Ukraine; 2Department of Neurology, Tbilisi State Medical University, Tbilisi, Georgia ...
Elimam N   +4 more
doaj  

Principles of OCTA and Applications in Clinical Neurology

open access: yesCurrent Neurology and Neuroscience Reports, 2018
Purpose of ReviewThe article reviews the recent findings on the use of optical coherence tomography angiography (OCTA) in neurology.Recent FindingsOCTA is a new addition to the powerful and complementary technology of the OCT. Due to its noninvasiveness,
A. Wylęgała
semanticscholar   +1 more source

Longitudinal Study of Salivary Biomarkers in the Definition of Clinico‐Molecular Progression of Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Longitudinal changes in salivary biomarkers in Parkinson’s disease (PD) from early (T0) to 4‐year follow‐up (T1), quantified by ELISA: oligomeric and total α‐synuclein, total and phosphorylated tau, MAP1LC3B (autophagy), and TNFa (inflammation). Blue arrows indicate direction of change at T1 vs T0 (up = increase; down = decrease).
Maria Ilenia De Bartolo   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy